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Abstract 
Cytochrome P450 2D6 (CYP2D6) is used to develop an approach for predicting affinity and relevant binding 
conformation(s) for highly flexible binding sites. The approach combines the use of docking scores and 
compound properties as attributes in building a neural network (NN) model. It begins by identifying segments of 
CYP2D6 that are important for binding specificity, based on structural variability among diverse CYP enzymes. A 
family of distinct, low-energy conformations of CYP2D6 are generated using simulated annealing (SA) and a 
collection of 82 compounds with known CYP2D6 affinities are docked. Interestingly, docking poses are observed 
on the backside of the heme as well as in the known active site. Docking scores for the active site binders, along 
with compound-specific attributes, are used to train a neural network model to properly bin compounds as 
strong binders, moderate binders, or nonbinders. Attribute selection is used to preselect the most important 
scores and compound-specific attributes for the model. A prediction accuracy of 85 ± 6% is achieved. Dominant 
attributes include docking scores for three of the 20 conformations in the ensemble as well as the compound's 
formal charge, number of aromatic rings, and AlogP. Although compound properties were highly predictive 
attributes (12% improvement over baseline) in the NN-based prediction of CYP2D6 binders, their combined use 
with docking score attributes is synergistic (net increase of 23% above baseline). Beyond prediction of affinity, 
attribute selection provides a way to identify the most relevant protein conformation(s), in terms of binding 
competence. In the case of CYP2D6, three out of the ensemble of 20 SA-generated structures are found to be 
the most predictive for binding. 
Introduction 
Drug lead screening has been an active area of research for many years. Due to the tedious and expensive 
nature of experimental screening procedures, computational compound screening has been pursued extensively 
in recent years.1 Approaches often incorporate molecular docking simulations into the virtual screening 
process.2,3 Traditionally, a major limitation of docking algorithms has been a lack of protein flexibility, which 
would otherwise require excessive computation time to process. This limitation is known as the “protein docking 
problem”. To compensate, some docking applications permit limited binding site side-chain movement in order 
to introduce some flexibility within the protein target;4 nevertheless, there still exists a need for backbone 
movement in order to fully capture the physiologically relevant binding conformation(s). Furthermore, even 
under optimal conditions, docking alone is usually not very predictive of binding affinity for flexible proteins and 
may therefore benefit by supplementing with 1D QSAR models to enhance predictability. 
While an exhaustive simulation of 3-dimensional protein search space is currently infeasible because of 
computational limitations, knowledge-based inferences can be used to reduce the complexity of the protein 
docking problem. For example, consideration of movement only around the binding site may sufficiently 
preclude unnecessary search space. Since binding sites tend to comprise a small percentage of a protein's 
volume, a simulation of the binding site alone will significantly reduce the search complexity. Additionally, 
certain segments of the protein are likely to be less important than others for the binding process. By excluding 
such segments from consideration when evaluating binding site flexibility, the search space is further restricted. 
Such an approach to docking is best developed on a model enzyme system with a highly flexible binding site. 
A well-known enzyme family responsible for the metabolism of a multitude of drug compounds and other 
xenobiotics is the cytochrome P450 (CYP) family. The CYP family has the broadest substrate specificity of any 
enzyme family. These monooxygenases, or mixed-function oxidase enzymes, metabolize the majority of 
clinically utilized drugs. The CYPs are heme proteins, whose central iron is the site of oxidation in the active site. 
Among the prominent drug-metabolizing CYPs in humans is CYP2D6, a liver enzyme that metabolizes 20−25% of 
all drugs.5 CYP2D6 is of particular interest in the pharmaceutical industry because many of its substrates cannot 
be metabolized by other enzymes, and overly rapid metabolism leads to short serum half-life for a drug. 
Furthermore, inhibition of CYP2D6-based metabolism of one drug by another drug can lead to dangerous 
drug−drug interactions. CYP2D6 is an especially good model system for our studies, because of its broad 
substrate specificity. Over 400 ligands have recently been reported6 for CYP2D6, of which ∼60% are substrates 
and ∼40% are inhibitors. To accommodate such a wide range of ligands must require significant binding site 
flexibility and malleability, which is not easily modeled using most current docking approaches. The docking 
process described herein is specifically designed to address binding site flexibility. The only other CYP isoforms 
that bind more substrates and inhibitors than CYP2D6 are CYP3A4 and CYP2C, but our studies begin with 
CYP2D6 because the class of ligands bound by it is more easily identified―it generally prefers to bind amines. 
Future studies will be directed to the somewhat more challenging CYP3A4 and CYP2C isoforms. 
In this paper, we present an approach to circumventing the protein docking problem and improving the 
predictability of binding affinities, using CYP2D6 as the target enzyme. There are 4 major steps in the process:  
(1) identification of structurally invariant segments of a protein, across the gene family to which it belongs; (2) 
conformational sampling, while retaining low-energy structures; (3) molecular docking of inhibitors into these 
distinct, low-energy protein conformations; and (4) attribute selection and construction of neural network (NN) 
models based on docking scores and compound-specific attributes. 
The first step identifies portions of the protein that are not expected to be important for binding specificity. This 
is done by performing 3D alignment with other human CYPs and labeling sections of the backbone that have a 
high degree of 3D structural homology across that gene family. Given that these other CYPs bind different 
substrates, it can be inferred that these “highly homologous” (structurally conserved) segments are not 
important for binding specificity and can therefore be kept fixed during molecular dynamics conformational 
sampling and subsequent docking studies. 
The second step utilizes molecular dynamics (MD) to generate multiple conformations of CYP2D6. The highly 
homologous segments identified in step 1 are held fixed during dynamics, thereby precluding their contribution 
to conformational fluctuations. Twenty CYP2D6 conformations are selected, which have distinct binding sites 
and yet still retain low-energy conformations. 
The third step involves automated docking of a set of 82 inhibitors with known binding affinities for CYP2D6. 
These compounds are docked into all 20 protein conformations, and the binding affinities are calculated using 
two different scoring functions. Ultimately, we seek to identify structures that allow for more accurate docking 
simulations, i.e., calculated binding affinities that are closer to the true affinities. Since docking scores alone are 
often not highly predictive of affinity, these are supplemented with other data in step 4. 
The fourth step uses the docking scores as attributes, along with compound-specific attributes (molecular 
weight, AlogP, etc.), to generate neural network models that predict binding affinity. In addition to generating 
models, this process also identifies protein conformations that may be most relevant for inhibitor binding. This 
information is obtained from the attribute selection process, in which protein conformations that are most 
predictive of binding affinities are selected. 
Results and Discussion 
3D Alignment.  
Altogether, 9 segments comprising 82 residues, are found to be highly homologous (structurally conserved) 
between the 9 CYP structures aligned in 3D space. These are shown in blue in Figure 1, which shows a “cartoon” 
representation of CYP2D6 secondary structure, viewed from above the binding site. The white surface behind 
the green heme is the proximal cysteine ligand, common to all CYPs. Of special interest is the structural 
conservation of the long I helix, which sits on top of the heme and comprises a wall of the active site pocket. This 
structural conservation is disrupted in the region of helix I that comprises the active site wall and which has a 
well-known distortion/kink, that may have functional relevance. This region is apparent as the red segment 
above the heme. 
 
Figure 1 Structural invariance in CYP2D6. Highly homologous (structurally conserved) segments of CYP2D6, 
compared to other CYPs, are colored in blue. 
While 115 total residues are found to be structurally conserved across the CYPs, a requirement that there be 4 
contiguous residues that are structurally conserved across all 9 protein structures reduced this to 82 residues 
(shown in blue in Figure 1). A cutoff of 4 sequential residues is chosen to avoid random correlations between 
structures, such as β-turns and crossings of the backbone, which would not constitute a true structural 
alignment of the CYP backbone residues. Since a secondary structural element usually consists of at least 4 
residues, this seemed to be an appropriate threshold to ensure true backbone structural alignments across the 9 
structures. 
Given that these segments are extremely similar in 3D positioning between multiple CYP enzymes (2C8, 2C9, and 
3A4) and given that these enzymes also have different substrates bound (3 with 2C9 and 4 with 3A4), it can be 
inferred that these structurally homologous segments are less significant for binding specificity than other 
regions of the protein. Consequently, these portions of CYP2D6 are immobilized during the MD simulations, to 
simplify the calculations and to prevent conformational changes associated with their movement. 
Molecular Dynamics.  
The MD (molecular dynamics) calculations generated 20 protein structures that have overall low potential 
energies and whose binding site atoms are distinct in 3D space. Twenty conformations are sought so as to 
capture a range of binding site conformations, while 3-dimensional distinction is necessary to produce 
nonredundant structures for docking calculations. It is important to maintain conformations with low potential 
energy, which indicates stability and therefore greater concentration in solution. The structurally homologous 
segments of CYP2D6 are kept rigid during the MD simulations. Specifically, the Cα atoms for these residues are 
held fixed, such that large structural changes cannot take place in close proximity to these segments. Significant 
conformational changes in the protein are limited to other regions, including the majority of the binding site 
residues. A first attempt at performing MD without significant heating generated little structural variation, with 
a 50 ps run at 400 K generating 50 000 structures that all differed by <0.8 Å RMSD from each other (Cα atoms). 
Hence, a simulated annealing (SA) approach is required to better sample conformational space. 
The 20 protein structures are generated by performing a SA heating protocol 20 times, using the same initial 
conformation. SA involves heating the system to an extremely high temperature and then cooling it slowly until 
it reaches a low-energy conformation. The SA protocol is often used to generate multiple low-energy 
conformers,7 since the extreme temperature allows the protein structure to escape local energy minima that 
would otherwise prevent significant conformational changes. The potential energy of the protein is assessed 
after each SA run and compared to the energy of the initial structure. Distinction between structures is assessed 
by measuring RMSD differences between atoms of binding site residues. These residues are selected by visual 
inspection of the active site pocket, using the program VMD.8 Figure 2 shows the binding site face of CYP2D6, as 
defined for the calculations performed herein, with the designated binding site residues specified in blue. 
 
Figure 2 Binding site of CYP2D6. Binding site residues for CYP2D6, as defined in this study, are colored in blue in 
either a cartoon (A) or surface representation (B). 
The SA calculations generate some significant fluctuations in side-chain and backbone conformations, although 
large shifts of helices and/or loops do not occur. Figure 3A shows backbone variation for the 20 SA runs. In this 
figure, the 20 structures are overlaid so as to illustrate the structural variation across the whole protein, 
although the structural conservation of helix I is apparent (the blue helix located above the heme). As expected, 
the F−G loop (left side of figure) shows significant variability. This variability is more apparent in Figure 3B, 
where only the variation of backbone residues around the active site cavity is shown. This figure illustrates the 
residues that are considered during RMSD calculations. Especially relevant for docking calculations is the 
variability that is observed for side chains of residues that have previously been reported to have a role in 
substrate and/or inhibitor binding (Figure 4). 
 
Figure 3 SA results for CYP2D6. Twenty overlaid conformations of CYP2D6, which resulted from the 20 separate 
SA runs, are shown either for the entire backbone (A) or for highly variable regions in and near the active 
site (B). 
 
Figure 4 Side-chain variability for active site and related residues. For the 20 structures generated in the SA 
process, side chains are shown for residues that are thought to be important for substrate and inhibitor binding:  
Asp301, Glu216, Phe120, Phe481, Phe483, and Val374. 
Docking.  
The third phase of this work utilizes the 20 protein structures for molecular docking simulations. To perform the 
docking, the program AutoDock 3.09 is used. Additionally, the graphical interface, AutoDockTools,10 is used to 
prepare the protein structures for the docking runs. 
A data set of 82 compounds, selected from an article by Kemp et al.,11 is used for automated docking. This data 
set consists of three smaller data sets of 21, 30, and 31 compounds, which are found in refs 12 and 13 and from 
NCI,14 respectively. After docking the 82 compounds 10 times each into each of the 20 structures, there are 
16 400 total docking results. In this case, a docking result consists of a calculated free energy of interaction (i.e. 
“score”) and a docked conformation of the compound within the protein (i.e. “pose”). The majority of these 
poses are located inside the binding site and close to the heme―where catalysis occurs (i.e. the active site). But, 
some poses are on the opposite side of the heme, outside of this active site. Figure 5A shows the 10 poses for 
one compound docked into one of the CYP2D6 structures. In this figure, nine of the 10 are inside the binding site 
near the heme, while the 10th, on the lower right, is on the other side of the heme. On this remote face of the 
heme there are two pockets that were found to be occupied with high frequency in the docking calculations, 
and they are summarized in Figure 5B for all of the dockings. For purposes of initial scoring, these distal site 
binders are ignored. But it is possible that this may actually be another inhibitor binding site, since it is at the 
protein−protein interaction interface where cytochrome P450 oxidoreductase (CYPOR) is thought to bind, so 
inhibitors could have an effect on reaction rate by interfering with electron transfer by disrupting the 
CYP/CYPOR complex. 
 
Figure 5 Docking poses. (A) Docking for one compound into CYP2D6 generated 10 poses:  9 in the active site and 
one on the backside of the heme. View is from above the active site side of the heme. (B) In analyzing all of the 
docking results, many poses are observed on the backside of the heme as summarized here. These are shown 
in CPK colors for the two clusters of poses relative to the heme prosthetic group, which is rendered as a green 
space filling model. View is from the back of the heme, opposite the active site. 
The AutoDock algorithm utilizes an internal scoring function to assess docking accuracy throughout the 
simulation. The resulting free energy score is essentially the final calculation of this function. In addition to 
AutoDock's scoring function, we rescore each set of 10 docked poses for each compound with X-Score,15 a 
stand-alone scoring function application. In previous studies comparing the ability of different scoring functions 
to accurately predict binding affinities for known protein−ligand complexes, X-Score was found to perform 
better than a number of other scoring functions.16,17 
Comparison of calculated free energy scores with the known affinities gives relatively poor correlations with 
both AutoDock and X-Score, with correlation coefficients no higher than 0.3 for any of the 20 structures. This is 
true whether correlations are made for the 82 compounds with each of the 20 protein structures, or whether 
the best score of the 20 structures is used in the correlation. Hence, a neural network (NN) approach is 
employed, whereby the docking scores are used as attributes along with compound-specific attributes to train a 
NN model. 
Neural Network Model.  
The 40 docking scores (20 AutoDock, 20 X-Score) are used as attributes for training neural network models, 
along with compound-specific attributes that include the following:  HA (number of hydrogen bond acceptors), 
HB (number of hydrogen bond donors), MW (molecular weight), number of rotatable bonds, ALogP, formal 
charge, number of aromatic rings, and number of positive atoms (Figure 6). A baseline NN model with all 
attributes and without scores for the second binding site is only slightly better than labeling all compounds as 
“binder” (63 ± 6% vs 62%). Including scores for the second binding site on the back of the heme (Figure 5) 
improves accuracy (73 ± 6%), suggesting it might be a relevant site. Attribute selection was done using five 
different search methods (Table 1). Rank search and exhaustive search improve accuracy slightly (74 ± 6%), 
while other attribute selection algorithms do not show improvements over using all attributes, with the second 
binding site scores. Analysis of the confusion matrices (Figure 7) reveals that although errors in classifying 
ligands as binders, nonbinders, or moderate binders do occur, the most serious misclassification of binder as 
nonbinder (and nonbinder as binder) is rare. Indeed, not a single such misclassification occurred in trial 3, where 
attribute selection was done using the genetic search. Only two such misclassifications occurred in trials 4 and 5 
(rank search and exhaustive search), which yielded slightly more predictive models overall. 
 
Figure 6 Neural network (NN) model. (A) Neural network graph of a typical model generated in this study. (B) 
Results of attribute selection using five different search methods. 
 
Figure 7 Confusion matrices for the five NN models presented in Figure 6B and Table 1. 
Table 1.  Attribute Selection Process 
trial search method attributes selected accuracy 
1 best first #pos atoms, AutoDock_2, AutoDock_4, AutoDock_6, AutoDock_7, 70.7 ± 6.5 
    AutoDock_13, X-Score_18   
2 greedy stepwise #pos atoms, AutoDock_2, AutoDock_4, AutoDock_6, AutoDock_13 68.3 ± 6.5 
3 genetic search formal charge, #aromatic rings, #HB, AlogP, X-Score_1, AutoDock_2, 70.7 ± 6.5 
    AutoDock_4, AutoDock_6, X-Score_8, AutoDock_9, X-Score_10,   




    AutoDock_1, X-Score_1, AutoDock_2, AutoDock_3, X-Score_3,   
    AutoDock_4, X-Score_4, AutoDock_5, X-Score_5, AutoDock_6,   






    AutoDock_14, AutoDock_16, AutoDock_17, X-Score_19   
 
Several interesting conclusions about protein conformations result from the classification and attribute 
selection. Protein conformation #6 (63 ± 6%) is found to provide the most predictive docking scores, followed by 
#5 (62 ± 6%) and #14 (62 ± 6%), suggesting they may represent relevant conformations of the CYP2D6 protein, in 
terms of binding competence. The only scoring attributes selected by at least four of the search methods are the 
AutoDock scores for docking into CYP2D6 conformations #2, #4, and #6 (see Table 2), suggesting the relevance 
of these protein conformations, relative to the other 17. Conformation #6 is selected only once with #5 and not 
at all with #14 (Table 1), suggesting these conformations have related binding site shapes that confer similar 
binding affinities. In contrast, conformations #2 and #4 complement #6 in terms of predicting binding affinity, so 
may represent different active site conformations that are sampled in solution in order to accommodate 
different ligands. It is especially noteworthy that all attribute selection trials resulted in the selection of multiple 
docking scores (Table 1), suggesting that an ensemble of protein conformations is involved in ligand recognition. 
Table 2.  Attribute Selection Frequency in Trials 1−5 
attribute count attribute count 
formal charge 3 X-Score_3 2 
#pos atoms 3 AutoDock_4 4 
#aromatic rings 3 AutoDock_6 4 
#HB 2 AutoDock_7 2 
AlogP 3 X-Score_8 2 
AutoDock_1 2 AutoDock_13 3 
X-Score_1 2 AutoDock_17 2 
AutoDock_2 4     
 
Of the compound-specific attributes, ALogP is the most predictive (71 ± 6%) followed by number of positive 
atoms (70 ± 6%). The most frequently selected compound-specific attributes are as follows:  formal 
charge, number of positive atoms, number of aromatic rings, and ALogP. However, since formal 
charge and number of positive atoms are common with only two of the five methods, they appear to correlate, 
as expected. So, consistent with what is already known for CYP2D6 substrates and inhibitors, CYP2D6 tends to 
bind hydrophobic compounds with a positive charge and an aromatic ring. Such attributes are highly predictive, 
since an accuracy of 74 ± 6% is achieved using formal charge, number of aromatic rings, and ALogP alone. 
Conversely, use of only docking scores as attributes provides a similarly high level of accuracy. Therefore, the 
next question we sought to address is:  does combined usage of docking scores and compound properties 
provide synergistic increases in accuracy? 
The answer to this question is yes including docking scores as NN attributes together with compound properties 
increases accuracy significantly. The effectiveness of docking scores as attributes is shown through the 
evaluation of several different NN structures in combination with various subsets of the attributes, all of which 
include at least one docking score. Three optimized NNs have accuracies of 78 ± 6%, and their architectures are 
detailed in the Experimental Section. But, this model was built using docking scores for a given protein 
conformation that is most predictive across the whole set of ligands in the training set, which may not accurately 
model the actual binding process. Since a flexible protein binding site might sample any of our 20 
conformations, different structures might be relevant for different ligands. That is, protein structure #6 might 
give the lowest energy complex for ligand A, while protein structure #10 might give the lowest energy complex 
for ligand B. To model this induced fit type of binding, we used as attributes the “best X-Score” or 
“best AutoDock score”, where best means the lowest energy pose for a given ligand, among the 20 possible 
CYP2D6 conformations. The most accurate NN model is obtained by using these docking score features. The 
resulting model (including also HA, MW, ALogP, formal charge, and number of aromatic rings) obtains an 
accuracy of 85 ± 6%, a significant improvement over the model constructed with docking scores using the same 
CYP2D6 conformation for all ligands (78 ± 6%) or without docking scores at all (74 ± 6%). Choosing 
the best docking score (and corresponding CYP2D6 conformation) is therefore much more predictive than 
forcing a single conformation across all ligands and is a physically more realistic model for enzymes with flexible 
binding sites, since it simulates “induced fit” binding. 
Analysis of the docking poses for all 82 ligands (Figure 8) provides some insight into structure−function 
relationships for binding site residues. It can be seen that there are clusters of ligands close to the heme as well 
as somewhat removed and extending to the F−G loop region. The latter ligands will be more challenging to dock 
and score accurately, since this region of the CYP structure in known to have the highest flexibility. Positively 
charged amines on ligands (colored blue) can be seen at various regions in the binding site, although proximity 
to Asp301 and Phe120 is seen for some of the higher affinity ligands (Figure 9), as expected.18,19 Interestingly, 
the cluster of 82 ligand poses assumes a U-shape, with the curvature apparently caused by steric interference 
from Leu484. This residue, along with Phe120, creates a 6 Å constriction in the binding site (Figure 9), defining a 
hydrophobic wall for ligands. It can be seen that X-Score and AutoDock scoring functions deal slightly differently 
with these interactions (Figure 8), although both show this type of U-shaped clustering due to Leu484. It should 
also be noted that although previous literature reports have suggested a role for Phe481/Phe48320,21 in 
binding16c,d our docking results suggest that these residues do not participate directly in binding. Rather, their 
location is such that they interact with the F−G loop, possibly locking it into place to permit proper formation of 
that surface of the binding site. It is also possible that Phe481/Phe483 interactions permit proper placement of 
Leu484 which is itself centrally located in the binding site (Figure 9B,C). 
 
Figure 8 Overlay of the 82 ligands bound in lowest energy poses, with energies calculated using the AutoDock (A, 
B) or X-Score (C, D) scoring function. Protein is CYP2D6 in conformation #6. 
 
Figure 9 Overlay as in Figure 8C,D, highlighting the effect of the hydrophobic wall comprised of Leu484 and 
Phe120 on cluster shape. (A) Protein has been removed for clarity to show how docking poses cluster in a U-
shaped manner. (B) Protein is rendered as a cartoon with heme (red), Asp301 (yellow), Leu484 (green), and 
Phe120 (blue) shown, demonstrating the proximity of Leu484 to the U-curve in the clustered poses (6 Å). (C) 
Rendering as in B, but only the 13 highest affinity ligands are shown (IC50 < 1 μM). 
Summary 
This study presents an approach to predicting binding affinity that implicitly considers binding site flexibility. 
It starts by identifying structurally conserved regions across a gene family, to determine regions to be kept fixed 
in subsequent simulated annealing runs, to generate multiple conformations for docking studies. Applied to 
CYP2D6, this results in 20 different conformations in which to dock potential ligands or inhibitors. The 
conformations that are most relevant for binding are selected by treating docking scores as attributes for a NN 
model and using attribute selection to identify those attributes (i.e. structures) that are most predictive of 
binding affinity. This NN/attribute selection strategy shows that only 3 out of 20 conformations of CYP2D6 are 
most relevant for binding. Binding affinity predictability is significantly enhanced by the inclusion of compound 
specific attributes as inputs to the NN model. In the case of CYP2D6, the most important compound specific 
attributes are the number of positive charges, ALogP (hydrophobicity), and the number of aromatic rings. This 
strategy therefore combines the benefits of 1D QSAR modeling with 3D docking and is able to achieve a 
prediction accuracy of 85 ± 6%. This approach implicitly includes a consideration of side-chain flexibility and the 
possibility of multiple binding modes, which is especially important for proteins with large and 
malleable/dynamic binding sites, like the CYPs. 
Experimental Section 
3D Alignment.  
The 3D alignment phase involves a homology model of CYP2D6 (created as described previously22) and Protein 
Data Bank (PDB)23 crystal structures for CYP2C8, CYP2C9, and CYP3A4. CYPs 2C9 and 3A4 have three and four 
available structures, respectively, due to crystallization with different substrates or inhibitors. These additional 
structures are included so as to expand the conformational search space. Altogether there are 9 PDB structures 
that are compared. CYPs 2C8 and 2C9 are dimers, with A and B chains:  only the A chains are used in the 
alignment. Furthermore, only Cα atoms are aligned. 
Segments of the CYP2D6 binding site are designated as less significant than others in determining binding 
specificity if they are found to be “highly homologous” (structurally conserved) among the other human CYPs. To 
assess structural homology, rigorous 3D alignment is performed. While sequence alignment is a useful approach 
for deciphering protein homology, a 3D alignment is more appropriate for this problem, given the 3D nature of 
the search space. 
There are 2 overall steps to the 3D alignment phase:  (1) a coarse-grained, global alignment and (2) a fine-tuned, 
local alignment. Both of these steps involve RMSD calculations using Cα atoms. The global alignment involves 
pairwise combinations of CYP2D6 with one of the other 8 structures, using the Combinatorial Extension24 (CE) 
3D alignment tool. This application performs iterative alignment of two protein chains using distance-based 
heuristics. The globally aligned pairs are then subjected to local alignment with an in-house Perl script, which 
uses a 1.5 Å RMSD window to designate individual residues as “highly homologous”. Segments of the backbone 
that have four contiguous highly homologous (structurally overlaid/proximal) residues in all nine structures are 
designated as highly homologous segments. 
Molecular Dynamics.  
The second phase of this work involves performing molecular dynamics (MD) simulations in order to generate 
20 distinct yet low-energy conformations. The CYP2D6 structure used in this work is minimized with the 
AMBER9425 molecular mechanics force field. Prior to molecular dynamics, the CYP2D6 structure is converted to 
the CHARMM2226 atom types, and energy minimization is performed. Both of these steps are carried out with 
the HyperChem version 7.5 (Hypercube, Inc.; Gainesville, FL) molecular modeling package. Steepest descent 
minimization is used to remove the large initial forces:  4600 cycles are performed, which leaves the energy well 
below 0 kcal/mol. This is followed by conjugate gradient minimization, which continues until the structure has a 
root-mean-square gradient of less than 0.1 kcal mol-1 Å-1. 
Version 2.5 of NAMD27 is used to perform the MD simulations. NAMD requires 4 input files―protein coordinates 
file, protein structure file (PSF, which contains information about atoms and geometries), force field parameter 
file, and NAMD configuration file. The coordinates and PSF files are generated with psfgen, a NAMD utility 
program, while the parameter file is obtained from the force field, CHARMM22 in this case. The dynamics are 
broken into 2 main phases, and thus 2 configuration files are used. The first phase involves energy minimization 
for 1 ps, followed by heating from 0 K to 300 K over 3 ps, and, finally, 200 ps of equilibration. The second phase, 
simulated annealing, heats the system from 300 K to 1000 K over 3 ps, keeps a constant 1000 K for 10 ps, and 
cools the system to 300 K over 10 ps. The simulated annealing protocol is performed 20 times, each using the 
same system configuration resulting from the first phase of dynamics. The highly homologous segments are held 
fixed during both dynamics phases. Scaled 1−4 interactions are used, with a 1−4 scaling of 1.0. Additional 
parameters include a time step of 1 fs, cutoff distance of 12.0 Å, switch distance of 10.0 Å, pairlist distance of 14 
Å, nonbonded frequency of 1, steps per cycle of 1, and dielectric of 1.0. 
An in-house Perl script is used to calculate the RMSD between individual corresponding atoms and then to 
calculate an average RMSD for the binding site. The script compares the average RMSD for each structure to 
every other structure (including the original structure), noting whether the difference is greater than 1.0 Å, the 
predetermined threshold. 
Molecular Docking.  
Molecular docking is performed with version 3.0 of AutoDock. To prepare the protein structures, AutoDockTools 
is used to assign partial charges and solvation parameters. AutoDockTools does not recognize nonstandard 
protein residues, such as the heme prosthetic group; however, the iron and pyrrole nitrogens are fully included 
in the final structures. This is accomplished by adding the heme partial charges to the protein files prior to 
running AutoGrid3 and changing the VDW and epsilon values for the M and X atoms in the protein GPF files 
prior to running AutoDock3. 
Preparation of the compounds for docking involves 5 or 6 steps, depending on the initial data. Three data sets, 
gleaned from Kemp et al.,11 are used in this work. These are designated the Ekins,12 Strobl,13 and NCI14 sets. The 
Ekins and Strobl sets are only available as drawings in the respective papers and therefore need to be drawn into 
2 dimensions. This is done with ChemDraw, a component of ChemOffice Ultra (CambridgeSoft Corp.; Cambridge, 
MA). The NCI set is available for download as 2D structures. The three data sets are converted into 3D with 
CORINA version 3.2 (Molecular Networks GmbH; Erlangen, Germany) and then minimized using Gaussian AM1 
calculations (revision C.02, Gaussian, Inc.; Wallingford, CT). The initial NCI set has 33 compounds, but two do not 
pass Gaussian minimization and are therefore discarded. Subsequently, the compounds are assigned atom types 
and converted to MOL2 format with Mol2Mol (version 5.02, Interware). Partial charges (Gasteiger) are then 
added with version 4.1.5 of Pipeline Pilot (SciTegic, Inc.; San Diego, CA). Finally, the program AutoTors, which is 
part of the AutoDock suite, is used to assign rotatable bonds and format the compounds for use with AutoDock. 
AutoDock's Lamarckian Genetic Algorithm (LGA) is used with all default values, and 10 runs are performed for 
each compound/CYP2D6-conformation pair. The GA component defaults include 50 initial individuals, 25 000 
maximum energy evaluations, or 27 000 maximum generations, an elitism of 1 individual, a mutation rate of 
0.02, and a crossover rate of 0.80. Additionally, a search space of 60 Å × 60 Å × 60 Å is used, which is more than 
sufficient to surround the entire protein. Each compound is docked into each CYP2D6-conformation 10 times, 
for a total of 200 docking runs per compound. 
Neural Network Model Construction.  
Multilayer perceptron neural network (NN) models are used to predict binding affinities for compounds. Each 
compound is represented by attributes, which include the 40 docking scores (20 AutoDock, 20 X-Score) and the 
following compound-specific attributes calculated with Pipeline Pilot:  HA (number of hydrogen bond acceptors), 
HB (number of hydrogen bond donors), MW (molecular weight), number of rotatable 
bonds, ALogP, formal charge, number of aromatic rings, and number of positive atoms (Figure 6A). Training and 
testing a NN requires data with known affinities. The Kemp data for the 82 compounds was used for training and 
testing with their affinities binned as “binder” (IC50 < 20 μM), “moderate binder” (20 μM ≤ IC50 < 500 μM), and 
“nonbinder” (IC50 > 500 μM). Since the data set contains 51 known binders out of 82 total compounds, a 
classifier that uses only the prior data distribution has an accuracy of 62% (51/82). Hence, accuracies greater 
than 62% are considered to be above chance. All data values were normalized to a [−1,1] scale using a linear 
transformation. 
The process of constructing the NNs involves two steps. The first step uses attribute selection algorithms to 
select highly predictive subsets of attributes from the initial 40 docking scores and 8 compound-specific 
attributes. Five search methods are used for attribute selection:  best first, greedy stepwise, genetic search, rank 
search (with information gain), and exhaustive search (Figure 6B). A C4.5 decision tree model, due to its efficient 
implementation, is used to evaluate attribute subsets. Use of multiple attribute search methods permits the 
construction of different NN models. This strategy of exploring model space using different feature sets was 
chosen over a GA-based construction of multiple models, because it avoids the need to combine models using 
techniques such as voting or regression modeling. 
The second step in constructing NNs involves selecting a NN architecture and a training duration. NNs are highly 
parametrized models, and the following paragraphs elaborate on model architectures investigated. A 10-fold 
cross-validation is used to evaluate NN accuracy. In 10-fold cross-validation,28 the data are partitioned into 10 
nonoverlapping and approximately equal sized sets. A neural network model is trained on 9 of the 10 partitions, 
and its accuracy is measured on the 10th. This process is repeated so that each partition is used as a test set. The 
accuracy estimate is therefore the average accuracy obtained across the 10 folds. The error estimates are 
obtained from the accuracy variance across the 10-folds. Because the test set is not used when training the 
model, accuracy estimates are not subject to overfitting effects. Indeed, when our best neural network model is 
trained and tested on the same set of 82 compounds, the accuracy is 92%, which would be an overestimate of 
accuracy and indicative of overfitting. It should also be noted that since we are not predicting numeric affinities, 
but rather are predicting categories of affinities, cross-validation is the best approach for measuring accuracy (as 
opposed to R2 and Q2). Weka version 3.4.429 is used to perform attribute selection and NN design, training, and 
testing. 
A systematic NN architecture is used to evaluate the results of attribute selection, resulting in a total of 6 NNs 
(one using all compound attributes, and one for each of the five attribute selection algorithms). The NN 
architecture consists of an input layer with one node per selected attribute, an output layer with three nodes 
(one for each affinity bin), and a single hidden layer with the number of nodes given by (#attributes + #bins)/2. 
Each node uses the logistic activation function. Training uses back-propagation for 500 epochs, where 1 epoch 
involves propagating each of the 82 instances through the NN. 
Additional architectures are constructed using insights from the authors to improve on systematically 
constructed NNs. Three optimized NNs are described. The first NN uses the first nine attributes (formal 
charge, #aromatic rings, AlogP, AutoDock 1, X-Score 3, AutoDock 13, AutoDock 14, AutoDock 16, AutoDock 17) 
selected using Weka's exhaustive search, one hidden layer with six neurons, and 500 epochs for training. The 
second NN architecture uses the first nine attributes (formal charge, #pos atoms, #aromatic 
rings, #HA, #HB, MW, AlogP, #rot bonds, AutoDock 1) selected using Weka's rank search and has two hidden 
layers with a “5−2” scheme and 550 epochs for training. The final NN architecture uses the first nine attributes 
(formal charge, #aromatic rings, #HB, AlogP, X-Score 1, AutoDock 2, AutoDock 4, AutoDock 6, X-Score 8) selected 
using Weka's genetic search and has two hidden layers with a “5−2” scheme and 500 epochs for training. Back-
propagation and logistic activation functions are used as described in the previous paragraph. 
The best NN uses the two most predictive docking score features, “best” AutoDock score and “best” X-Score 
score, along with five compound features:  HA, MW, ALogP, formal charge, and number of aromatic rings. The 
NN containes a single hidden layer with five nodes (determined by (#attributes + #bins)/2) and uses 500 epochs 
for training. Back-propagation and logistic activation functions are used as described above. 
Note Added in Proof.  
Since the completion of this study, a 3.0 Å resolution crystal structure of human CYP2D6 (pdb code 2F9Q) was 
published.30 This structure validates the CYP2D6 model used in our study (1.66 Å backbone RMSD difference, for 
288 residues), with the highest structural match being in the binding site. The difference between our model 
and the crystal structure is less than the resolution of the crystal structure and is in any case sampled using our 
MD analysis. Greatest variation is in the F−G loop region, which is known to be dynamic, and was doubly 
mutated in the crystal structure to increase solubility. 
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